Tuesday July 17, 2018
Home India Deaf-mute Gee...

Deaf-mute Geeta, stuck in Pakistan for 13 years, arrives in Delhi

0
//
79
Republish
Reprint

New Delhi: Geeta, a deaf-mute Indian woman who had been stranded in Pakistan for over a decade, arrived in New Delhi on Monday accompanied by five members of Edhi Foundation, a social welfare organisation, who had been generously looking after her since 2003.

Geeta – whose heartrending story bears an uncanny resemblance to that of a character named ‘Munni’ in the Bollywood blockbuster Bajrangi Bhaijaan – was unable to return home, for she could not remember or explain where she was actually from.

External affairs ministry spokesperson Vikas Swarup said the members of Edhi Foundation will be treated as state guests.Geeta

“On October 26, 2015, we will be bringing Geeta back to India. Together with Geeta, we have invited five officials of the Edhi Foundation,” Swarup had said on Friday.

He said that Geeta has already identified one family as possibly being that of her parents.

“We will be doing DNA testing to establish conclusive proof. If the DNA tests match, Geeta will be handed over to that family. If not, we have identified suitable institutions where she will be looked after,” Swarup said.

He said on the institutions identified are in Delhi and Indore.

Bilkis Edhi’s grandson Fahad said,  “She will be accompanied by me, my father Faisal Edhi, my mother and my grandmother Bilqees Edhi…We are going with her because she recognised the family in the photograph sent to us by the Indian High Commission as her family. But DNA tests will confirm this.”Geeta

The Express Tribune reported, Geeta took with her all the gifts she received in the past few years – including a gold-jewellery set from Bilquis Edhi, a silver-jewellery set from Faisal Edhi on Raksha Bandhan and a gold chain with a pendant that bears her name.

“We have also packed some dresses for her to wear on Diwali next month,” said Saba Edhi.

In a bid to express her gratitude to the people of Pakistan, Geeta used the sign language to say she felt blessed to be in that country, as translated by her instructor Ishrat Shaheen.

“She will never forget how much love and respect Pakistan has given her.”

Geeta also promissed to keep in touch with her instructor and friends via internet video chat.Geeta

Geeta, now in her early 20s, was around 11 years old when she inadvertently crossed the border to Pakistan.

In 2003, Geeta — then 11 years old — was spotted by the Pakistan Rangers in Lahore, and handed over to the Edhi Foundation. Bilquis Edhi, who runs the Edhi Foundation, has named her Geeta.

(With inputs from IANS)

Click here for reuse options!
Copyright 2015 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)